These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30358727)

  • 1. Evolution of postmenopausal hormone therapy between 2002 and 2009.
    Ettinger B; Wang SM; Leslie RS; Patel BV; Boulware MJ; Mann ME; McBride M
    Menopause; 2018 Nov; 25(11):1306-1312. PubMed ID: 30358727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of postmenopausal hormone therapy between 2002 and 2009.
    Ettinger B; Wang SM; Leslie RS; Patel BV; Boulware MJ; Mann ME; McBride M
    Menopause; 2012 Jun; 19(6):610-5. PubMed ID: 22207318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative.
    Steinkellner AR; Denison SE; Eldridge SL; Lenzi LL; Chen W; Bowlin SJ
    Menopause; 2012 Jun; 19(6):616-21. PubMed ID: 22648302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
    Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
    Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
    Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
    Menopause; 2018 Nov; 25(11):1297-1305. PubMed ID: 30358726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
    Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
    Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parameters of lipid metabolism in postmenopausal women on oral or transdermal hormone replacement with or without progesterone].
    Foth D; Römer T; Benthin A
    Zentralbl Gynakol; 2000; 122(9):483-8. PubMed ID: 11050765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
    Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
    Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National use of postmenopausal hormone therapy: annual trends and response to recent evidence.
    Hersh AL; Stefanick ML; Stafford RS
    JAMA; 2004 Jan; 291(1):47-53. PubMed ID: 14709575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.